Loading company
Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Icon plc and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$194.71-2.8%Nov 13 close
Figures through September 30, 2026, from the 6-K filed October 27, 2026
ICON sells clinical-trial management, testing and patient-recruitment services to drug, biotechnology and medical-device companies and public-health organizations.